Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (22 ops.)
Latest filing published 18 Sept 2026 for CRESCENT BIOPHARMA, INC., €8,814. Read the official filing
Filing timeline
BuySaleRichard William Scalzo
Insider track record
Disclosed buys
0
Disclosed sells
22
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Richard William Scalzo: trading record in brief
Richard William Scalzo discloses dealings in 2 companies, chiefly Dyne Therapeutics, Inc. and Crescent Biopharma, Inc. Over a trading history stretching from 20 September 2021 to 16 September 2026, the count stands at 35 filings.
The open-market record consists of 22 sales worth €629k, with no purchase. The totals exclude 1 filing filed without an amount. The rest of the record consists of 5 share grants and 5 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The record was last updated on 18 September 2026 with an open-market sale (€8,814) in Crescent Biopharma, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Richard William Scalzo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations35 total
568 shares@ US$17.90Ordinary SharesSEC:0001628280-26-062705:0
1,112 sharesOrdinary SharesSEC:0001628280-26-044890:0
14,422 sharesOrdinary SharesSEC:0001628280-25-057681:0
1,343 shares@ US$11.381.3% of flowCommon StockSEC:0000950170-25-038731:0
917 shares@ US$11.831.0% of flowCommon StockSEC:0000950170-25-035490:0
2,488 shares@ US$13.953.1% of flowCommon StockSEC:0000950170-25-022455:0
1,455 shares@ US$28.123.7% of flowCommon StockSEC:0000950170-24-135570:0
32,700 shares0Common StockSEC:0000950170-24-134075:0
2,735 shares@ US$28.207.0% of flowCommon StockSEC:0000950170-24-127992:0
1,390 shares@ US$34.554.1% of flowCommon StockSEC:0000950170-24-108153:0
1,468 shares@ US$31.894.0% of flowCommon StockSEC:0000950170-24-105515:0
6,502 shares@ US$5.543.1% of flowCommon StockSEC:0000950170-24-105123:0
2,442 shares@ US$45.019.4% of flowCommon StockSEC:0000950170-24-099128:0
1,590 shares@ US$30.234.2% of flowCommon StockSEC:0000950170-24-072140:0
2,126 shares@ US$28.205.2% of flowCommon StockSEC:0000950170-24-062077:0
68,919 shares@ US$5.5433.2% of flowCommon StockSEC:0000950170-24-030482:0
2,273 shares@ US$25.855.1% of flowCommon StockSEC:0000950170-24-029603:0
3,429 shares@ US$1.030.3% of flowCommon StockSEC:0000950170-24-024298:0
13,000 shares@ US$1.031.2% of flowCommon StockSEC:0000950170-24-008061:0
13,000 shares@ US$1.031.2% of flowCommon StockSEC:0000950170-24-002277:0
2,376 shares@ US$12.022.5% of flowCommon StockSEC:0001209191-23-058666:0
1,380 shares@ US$10.721.3% of flowCommon StockSEC:0001209191-23-058332:0
681 shares@ US$12.010.7% of flowCommon StockSEC:0001209191-23-057671:0
89,742 shares0Common StockSEC:0001209191-23-055533:0
1,290 shares@ US$9.4113.0% of flowCommon StockSEC:0001209191-23-050174:0
25 of 35 declarations
